Patients News | pharmaphorum

News

"Significant shift" as NICE widens prostate cancer drug use

NICE has changed unpopular guidance on abiraterone for hormone-sensitive prostate cancer after the entry of generics into the UK market.

News

Blue ribbon for prostate cancer awareness

As UK mulls prostate cancer screening, study shows benefit

New data have shown that the balance between the benefits and harms of prostate cancer screening has improved with longer follow-up.

News

Falling flu vaccine sales in US stall CSL's Seqirus spinout

CSL says flu vaccination rates in the US are expected to fall 12% to 14% this year, and have scuppered its plan to spin out its vaccines unit Seqirus.

News

Texas sues J&J, Kenvue over Tylenol autism claim

Texas has filed a lawsuit against J&J and Kenvue over the debunked claim that Tylenol causes autism, recently trumpeted by President Trump.

News

Four women, seen from the back, hold each other behind each's back

Campaign seeks to plug HIV care gap for UK women

ViiV's campaign wants communication between women and healthcare workers about HIV to move beyond harmful stereotypes and 'risk' labels.

News

CRISPR biotech Intellia plummets as trial paused for safety

Intellia lost 45% of its value today as phase 3 trials of one of its priority drug programmes were halted due to a patient being hospitalised.

"Significant shift" as NICE widens prostate cancer drug use

As UK mulls prostate cancer screening, study shows benefit

Falling flu vaccine sales in US stall CSL's Seqirus spinout

Texas sues J&J, Kenvue over Tylenol autism claim

Campaign seeks to plug HIV care gap for UK women

CRISPR biotech Intellia plummets as trial paused for safety

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks